No Data
Yingkang Life: 2024 Annual Report Summary
Yingkang Life: 2024 Annual Report
INKON Life Technology (300143.SZ) announced its performance for 2024, with a net income of 0.115 billion yuan, an increase of 14.92%.
INKON Life Technology (300143.SZ) released its annual report for 2024, and the company's revenue is 1.559 billion...
INKON Life Technology (300143.SZ): Currently, there is no collaboration with Huawei Medical large model.
On February 19, Gelonghui reported that INKON Life Technology (300143.SZ) stated on the investor interaction platform that the company has not yet collaborated with Huawei Medical's large model. INKON Life Technology has been focusing on "AI + Medical" since 2021 and has currently introduced an intelligent interaction platform built with the capabilities of Iflytek Co.,ltd. The platform has officially launched at Shanxi INKON Life Technology General Hospital, marking a milestone in the company's innovative applications in the AI medical field, transitioning into a new phase of full-scenario applications. In the future, INKON Life Technology will continue to drive AI + clinical medical applications, explore AI innovation applications, promote AI product research and development, and create a comprehensive health system for users.
INKON Life Technology (300143.SZ): Currently, it has not yet integrated with the DeepSeek large model.
On February 19, Gelonghui reported that INKON Life Technology (300143.SZ) stated on the investor interaction platform that the company has not yet integrated with the DeepSeek large model. However, the group's health ecosystem brand, INKON One Life's AI platform, INKON Brain, and digital intelligence products have recently integrated with the DeepSeek-R1 large model. INKON Life Technology will arrange relevant work according to the group's unified deployment and will continue to drive innovation in AI applications in clinical medicine, advance AI product research and development, and create a new model for comprehensive user health management throughout the entire cycle.
INKON Life Technology (300143.SZ): Recently introduced an intelligent interactive platform built using the model capabilities of Iflytek Co.,ltd.
Glory Holdings reported on February 19 that INKON Life Technology (300143.SZ) stated on the investor interactive platform that the company recently introduced an intelligent interactive platform built with the large model capabilities of Iflytek Co.,ltd. It has officially launched at the Shanxi INKON Life General Hospital, marking a milestone in the company's innovative application in the AI Medical field as it steps into a new stage of full-scenario application. Since 2021, INKON Life Technology has laid out the "AI + Medical" strategy, focusing on three main directions: "precise diagnosis and treatment," "enhancing patient experience," and "refined operation," along with "3D visualization scenarios," "imaging diagnostic scenarios," "case generation scenarios," "radiation therapy scenarios," "intelligent follow-up scenarios," and "smart...